Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …

Purpose The genetic polymorphism was one of the major considerations for adjusting doses
of warfarin in Thai individuals. As a result, new oral anticoagulants (NOACs) were …

We compared the effectiveness and safety of direct oral anticoagulants (DOAC) vs patient
self-managed warfarin therapy (PSM) in patients with atrial fibrillation. We linked …

Background Anticoagulant therapies are used to prevent atrial fibrillation-related strokes,
with warfarin and direct oral anticoagulant (DOAC) the most common. In this study, we …

Background: In the clinical setting, the economic benefits of direct oral anticoagulants
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …

Abstract Introduction Novel oral anticoagulants (NOACs) and warfarin care bundles (eg
genotyping, patient self-testing or self-management) are alternatives to usual warfarin care …

Real-World Evidence (RWE) refers to any “data used for decision-making that are not
collected in conventional Randomised Controlled Trials (RCTs), and is increasingly used in …

ABSTRACT BACKGROUND The decision as to whether to use more expensive novel oral
anticoagulants (NOACs) or invest resources for quality improvement of warfarin therapy …

Aims A third of non-valvular atrial fibrillation (NVAF) patients are non-adherent to direct oral
anticoagulants (DOACs). Estimates of the economic value of full adherence and the cost of …

Background Oral anticoagulation with warfarin is the cornerstone therapy in atrial fibrillation
(AF) for stroke prevention. Multi-disciplinary anticoagulation management services have …